Skip to main content
. 2024 Jul 10;17(7):925. doi: 10.3390/ph17070925

Table 1.

Total number of biosimilars approved until 2023 by the eight countries analyzed.

Countries and Sources Total Number Approved Regulatory Framework for Biosimilars
Canada [134] 53 (September 2023) CMA
Brazil [135] 52 (May 2023) ANVISA
United States [136] 45 (December 2023) FDA
Australia [137] 43 (September 2023) TGA
Japan [138] 32 (December 2022) PMDA
South Korea [108] 25 (December 2022) MFDS
Argentina [126] 24 (December 2022) ANMAT
South Africa [139] 5 (November 2020) SAHPRA